Covered recipient · General Payments record
JEAN P MCDONOUGH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$3,583.26
- Reported across 187 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $461.66 | 17 |
| Education | $94.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SHIELD THERAPEUTICS INC | $200.24 | 2 |
| Astellas Pharma US Inc | $191.00 | 7 |
| Novo Nordisk AS | $45.63 | 2 |
| Exeltis, USA Inc. | $39.64 | 2 |
| Organon LLC | $32.80 | 3 |
| Medtronic, Inc. | $29.64 | 1 |
| ABBVIE INC. | $16.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.71 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105000253 | CMS |
| Astellas Pharma US Inc | $14.60 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139277624 | CMS |
| Astellas Pharma US Inc | $16.88 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139299530 | CMS |
| Astellas Pharma US Inc | $94.00 | 03/21/2024 | Education | Undisputed | 01/23/2026 | 1139345742 | CMS |
| Astellas Pharma US Inc | $14.44 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139338484 | CMS |
| Astellas Pharma US Inc | $19.68 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139371009 | CMS |
| Astellas Pharma US Inc | $16.56 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139348298 | CMS |
| Astellas Pharma US Inc | $14.84 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139446450 | CMS |
| Exeltis, USA Inc. | $20.64 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149999164 | CMS |
| Exeltis, USA Inc. | $19.00 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149999166 | CMS |
| Medtronic, Inc. | $29.64 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119542501 | CMS |
| Novo Nordisk Inc | $21.38 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097645493 | CMS |
| Novo Nordisk Inc | $24.25 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096768149 | CMS |
| Organon Llc | $6.64 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136190412 | CMS |
| Organon Llc | $6.48 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136190414 | CMS |
| Organon Llc | $19.68 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136190416 | CMS |
| SHIELD THERAPEUTICS INC | $100.12 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150115745 | CMS |
| SHIELD THERAPEUTICS INC | $100.12 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150115747 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.